Figure 2From: Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in FranceChanges of PSA values between baseline (blue boxes) and 3-months (red boxes) for patients receiving <3 months (left panel) or > = 3 months (right panel) of AA. The dots correspond to extreme values of PSA levels.Back to article page